Obesity and Low Target Attainment Rates in Chinese with Type 2 Diabetes

Xing-Bo Cheng,Yi-Ting Hsieh,Shih-Te Tu,Ming-Chia Hsieh
DOI: https://doi.org/10.1016/j.ejim.2012.02.015
IF: 7.749
2012-01-01
European Journal of Internal Medicine
Abstract:Background: Although it is known that the prevalence of type 2 diabetes and obesity is increasing in China, there is little research into how obese or non-obese patients may differ in their attainment of treatment goals for type 2 diabetes. To do this, we assessed the attainment of American Diabetes Association (ADA)-recommended goals in Chinese with type 2 diabetes stratified by body mass index (BMI).Methods: This cross-sectional study enrolled 520 Chinese with type 2 diabetes to find out if they had attained the following ADA-recommended goals: HbA1c<7%, SBP<130 mm Hg, DBP<80 mm Hg, LDL-C<100 mg/dl, TG<150 mg/dl, HDL-C>40 mg/dl for men and >50 mg/dl for women.Results: Only 44.4% of all participants achieved the blood pressure goal, 20.8% the HbA1c goal, 44.8% the LDL-C goal, 43.3% the HDL-C goal, and 66.8% the triglyceride goal. Obese patients were less likely than normal weight patients to achieve the blood pressure goal (OR, 0.474; 95% CI, 0.231-0.973; p=0.01), the HDL goal (OR, 0.365; 95% CI, 0.163-0.817; p=0.01), or the triglyceride goal (OR, 0.416; 95% CI, 0.212-0.817; p=0.01), after adjusting for confounders. Compared to normal weight participants, the obese patients had a significantly higher prescription rates for statin, metformin and anti-hypertensive drugs.Conclusion: Obese diabetic patients were less likely to achieve the blood pressure, LDL-C, HDL-C and triglyceride targets even when they were receiving several drugs to help them meet their target treatment goals. More strategies are needed to improve the treatment of Chinese with type 2 diabetes, particularly those who are obese. Crown Copyright (C) 2012 Published by Elsevier B. V. on behalf of European Federation of Internal Medicine. All rights reserved.
What problem does this paper attempt to address?